Phase II study of durvalumab plus olaparib as maintenance therapy in extensive-stage small-cell lung cancer (TRIDENT): Preliminary efficacy and safety results

被引：0

作者：

Huang, Yan

Jia, Jun

Wang, Qiming

Liu, Xianling

Zhang, Li

机构：

[1] State Key Lab Oncol South China, Guangzhou, Peoples R China

[2] Southern Med Univ, Affiliated Dongguan Hosp, Dongguan Key Lab Precis Diag & Treatment Tumors, Dongguan, Peoples R China

[3] Zhengzhou Univ, Henan Canc Hosp, Dept Internal Med, Affiliated Canc Hosp, Zhengzhou, Peoples R China

[4] Cent South Univ, Xiangya Hosp 2, Dept Oncol, Changsha, Peoples R China

[5] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Guangdong Key Lab, Guangzhou, Peoples R China

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8518

引用

页数：1